Bayer’s Ciprofloxacin DPI receives FDA orphan drug designation for NCFB treatment


Posted in: Medical Condition News | Pharmaceutical News

Tags: Antibiotic, Bronchiectasis, Ciprofloxacin, Clinical Trial, Cystic Fibrosis, Drugs, Fibrosis, Fluoroquinolone, General Medicine, Healthcare, Hematology, Neurology, Oncology, Pathophysiology, Respiratory, Respiratory Disease, technology